- Kaya Holdings (OTCQB:KAYS): Q2 Non-GAAP EPS of $0.01.
- Revenue of $0.25M (-13.8% Y/Y)
- Press Release
- More news on: Kaya Holdings, Inc., Earnings news and commentary, ,
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
KAYS CEO Craig Frank to receive The Sacred Mushroom's first Psilocybin Treatment FT. LAUDERDALE, FL / ACCESSWIRE / July 2, 2024 / Kaya Holdings, Inc. ("KAYS" or the "Company") (OTCQB:KAYS), announced today that its licensed psilocybin treatment center in Portland, Oregon, The Sacred Mushroom...
FT. LAUDERDALE, FL / ACCESSWIRE / June 5, 2024 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that its majority owned subsidiary, Fifth Dimension Therapeutics, Inc. has begun accepting appointments at its The Sacred Mushroom™ ("TSM") Psilocybin Treatment cen...
FT. LAUDERDALE, FL / ACCESSWIRE / May 7, 2024 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that the Company has been awarded its license to operate a Psilocybin Service Center by the Oregon Health Authority (the "OHA"). ...